Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
- Hm vi xng: Bn c th hm c Maca vi xng, gip mn n thm ngon ngt
May offer additional skin protection
A realistic GLP-1 weight loss timeline The first month is often about adjustment
Step 4: Schedule Your Consultation Depending on the provider, youll either: Have a live video consultation Complete an asynchronous evaluation (provider reviews and responds) Schedule a phone appointment What to Prepare: List of current medications and supplements Recent blood work results (if available) Questions about side effects, dosing, and expectations Information about any relevant medical conditions Step 5: Get Your Prescription If your provider determines GLP-1s are appropriate, theyll send a prescription to: A partner pharmacy (for compounded medications) Your local pharmacy (for brand-name medications) A mail-order pharmacy (for home delivery) Typical Timeline: Compounded medications: 3-7 days for delivery Brand-name medications: 1-3 days at local pharmacy (if in stock and insurance approves) Step 6: Start Treatment Your provider will typically start you on the lowest dose to minimize side effects: Semaglutide Starting Dose: 0.25 mg weekly for 4 weeks, then increase gradually Tirzepatide Starting Dose: 2.5 mg weekly for 4 weeks, then increase gradually What to Expect: Week 1-4: Side effects most common (usually mild nausea) Week 4-8: Appetite reduction becomes noticeable Week 8-12: Weight loss typically becomes visible (5-10 pounds) Month 3+: Continued steady weight loss (1-2 pounds per week) Step 7: Attend Follow-Up Appointments Regular check-ins allow your provider to: Monitor side effects Adjust dosage as needed Track weight loss progress Modify treatment plan if necessary Most programs schedule monthly follow-ups, though some offer more frequent support
Since FSA funds typically dont roll over into the next calendar year, its important to use them before the December 31st deadline
Such growth of diabetes-treatment-nave patients is partly a reflection of GLP-1s growing use as a first-line treatment in diabetes, but also demand for the weight loss benefits alone
